DEADPOOL — Cartalax + BPC-157 + TB-5

Deadpool is a proprietary VPeptide research blend combining three tissue repair and recovery-associated research peptides in a single lyophilized vial: 10mg Cartalax (Ala-Glu-Asp-Leu), a Khavinson-tradition tetrapeptide bioregulator associated with cartilage and connective tissue research; 5mg BPC-157 (Body Protection Compound-157), a pentadecapeptide fragment derived from gastric juice research; and 5mg TB-500 (thymosin β-4 fragment 17-23), a synthetic peptide sequence corresponding to a fragment of the thymosin β-4 protein. The blend is named "Deadpool" in reference to the character's rapid tissue regeneration properties in popular fiction — a naming convention chosen to reflect the tissue repair research focus of the three constituent peptides. Each peptide in the blend has an independent research literature history: BPC-157 in gastric peptide and tissue repair research (Sikiric and colleagues, University of Zagreb), TB-500 in thymosin β-4 fragment research (Goldstein and colleagues), and Cartalax in Khavinson-tradition short peptide bioregulator research (Khavinson and colleagues). This 20mg total-content vial is offered for laboratory research applications studying combined peptide pharmacology, comparative tissue repair peptide SAR, and multi-peptide formulation chemistry.

Benefits (Research Focus)

• Combined peptide pharmacology research — studied as a three-peptide combination for comparative pharmacology versus single-peptide administration

• Tissue repair peptide SAR — investigated across three distinct peptide classes (Khavinson tetrapeptide, gastric peptide fragment, thymosin fragment) for comparative SAR research

• Multi-peptide formulation chemistry — explored for stability, compatibility, and co-formulation research of three-peptide lyophilized preparations

• Comparative regenerative peptide research — examined for comparative research across three distinct tissue-repair peptide mechanism classes

• Convenience research format — single-vial format supports research protocols involving all three peptides simultaneously

What Researchers Look At

• Comparative pharmacology versus each single-peptide administration (BPC-157 alone, TB-500 alone, Cartalax alone)

• Three-peptide combination stability in solution and lyophilized form

• Comparative cell research model endpoints across distinct peptide mechanism classes

• Extracellular matrix and connective tissue research endpoints

• Peptide compatibility research in multi-peptide lyophilized formulations

Quick Specs

• Form: Lyophilized white powder (three-peptide blend)

• Total Peptide Content: 20 mg per vial

• Cartalax: 10 mg

• BPC-157: 5 mg

• TB-500: 5 mg

• Quantity: 1 vial

• Appearance: White to off-white lyophilizate

• Reconstitution: Bacteriostatic or sterile water (added by the end researcher)

• Purity: ≥99% by HPLC (each peptide component)

• Identity: MS-verified (per COA)

• Storage: Protect from light

Identity Basics — Component Peptides

• Cartalax: Ala-Glu-Asp-Leu (AEDL) — Khavinson-tradition tetrapeptide bioregulator

• BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (15 amino acids) — Body Protection Compound-157, gastric peptide fragment (Sikiric)

• TB-500: Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln (7 amino acids) — synthetic peptide corresponding to thymosin β-4 residues 17-23 (Goldstein)

• Class: Multi-peptide research blend combining three distinct peptide classes

• Total peptide content: 20 mg per vial (10 + 5 + 5)

• Blend name: "Deadpool" — proprietary VPeptide blend name reflecting the tissue repair research focus of the three constituent peptides

⚠️ Disclaimer

• This product is intended for laboratory research use only.
• Not for human or veterinary use.
• Not approved for diagnostic, therapeutic, or medical applications.
• Handle using appropriate laboratory safety procedures and personal protective equipment.

COA Verification Notice: Even if the vial label or product image states a certain concentration, always go by the COA for the true verified value. We reference the COA to determine the verified concentration and purity of each product, regardless of what the label or product image indicates.

Janoshik COA — Third-Party Testing

• [COA links for the Deadpool blend 20mg vial to be added once Janoshik testing is complete]